Hannah Brendan

Number of records: 6
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
21-Aug-24 6:38 PM
View: 
Quince Therapeutics, Inc. (QNCX) 21-Aug-24Purchase 30,845$0.63$19,336.8012%
265.69K to 296.54K
21-Aug-24 6:38 PM
View: 
Quince Therapeutics, Inc. (QNCX) 20-Aug-24Purchase 5,924$0.60$3,579.402%
259.77K to 265.69K
21-Aug-24 6:38 PM
View: 
Quince Therapeutics, Inc. (QNCX) 19-Aug-24Private Purchase 2,155$0.58$1,249.90< 1%
257.62K to 259.77K
05-Jun-24 2:37 PM
View: 
Quince Therapeutics, Inc. (QNCX) 04-Jun-24Option Exercise 56,061$0.55$30,833.6028%
201.56K to 257.62K
09-Aug-23 6:21 PM
View: 
Quince Therapeutics, Inc. (QNCX) 08-Aug-23Private Purchase 71,762$1.22$87,549.6055%
129.79K to 201.56K
23-May-22 8:07 PM
View: 
Quince Therapeutics, Inc. (QNCX) 19-May-22Grant 16,224----100%
0 to 16.22K